Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Gemcitabine for Advanced Salivary Cancer: A Phase II Study

Trial Profile

Gemcitabine for Advanced Salivary Cancer: A Phase II Study

Phase of Trial: Phase II

Latest Information Update: 23 Jan 2017

At a glance

  • Drugs Gemcitabine (Primary)
  • Indications Salivary gland cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Jan 2017 Status changed from active, no longer recruiting to completed.
    • 17 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top